This is a phase I study to assess the safety and tolerability of an oral preparation that may help patients with chronic hepatitis B in the future.
Study number | 5489 - RECRUITMENT CURRENTLY ON HOLD |
Group | People with chronic hepatitis B virus infection |
Gender | Male / Female |
Age | 18 - 65 |
Location | Liverpool |
Compensation | Reimbursement between £525 and £225 depending on participation. Reimbursement for out-of-pocket expenses such as travel, parking or meals with valid receipts |
Recruiting from | Apr 2018 |
Additional details | BMI must be between 18-32kg/m2. Involvement will be approximately 16 weeks. |